{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:38:55Z","timestamp":1792132735373,"version":"4.4.0"},"reference-count":55,"publisher":"The Endocrine Society","issue":"8","license":[{"start":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T00:00:00Z","timestamp":1652313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Shanghai Municipal Education Commission\u2014Gaofeng Clinical Medicine Grant Support","award":["20172025"],"award-info":[{"award-number":["20172025"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070885"],"award-info":[{"award-number":["82070885"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinical Research Plan of SHDC","award":["SHDC2020CR1017B"],"award-info":[{"award-number":["SHDC2020CR1017B"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>The comparative effectiveness of drugs and surgical therapy for women with obesity and polycystic ovary syndrome (PCOS) has not been systematically compared.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>We aimed to determine the difference in efficacy between drug and bariatric surgery therapy for women with obesity and PCOS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This prospective nonrandomized trial enrolled 90 women aged 18 to 40 years with body mass index (BMI)\u2005\u2265\u200527.5 kg\/m2 and waist circumference\u2005\u2265\u200585 cm and fulfilling the 2011 Chinese diagnostic criteria for PCOS; 81 subjects completed the study. In the drug group, patients were administered metformin and an oral contraceptive containing ethinyl-estradiol and cyproterone acetate for the first 6 months, and metformin alone for the second 6 months. In the surgical group, patients underwent laparoscopic sleeve gastrectomies. The follow-up period was 12 months. The main outcome was the complete remission of PCOS, requiring 6 consecutive regular menstruation cycles or spontaneous pregnancy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Median BMI at endpoint was 30.1 kg\/m2 in the drug group and 23.7 kg\/m2 in the surgical group; complete remission rate was 15% and 78%, respectively. Except endpoint BMI, no difference was observed in free androgen index, ovarian morphology, homeostasis model assessment for insulin resistance, and total weight loss between remission and nonremission patients. Logistic regression analyses also revealed that the final BMI was the major factor influencing the remission of PCOS. The cutoff points for the final BMI were 27.5 kg\/m2 for the drug group and 26 kg\/m2 for the surgical group. Overall, nearly 95% of patients with an endpoint BMI below the cutoff values achieved complete remission.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Complete remission of PCOS in patients with obesity depends on the final BMI after weight loss. Thus, bariatric surgery should be prioritized for these patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgac294","type":"journal-article","created":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T15:46:32Z","timestamp":1652370392000},"page":"e3217-e3229","source":"Crossref","is-referenced-by-count":77,"title":["Efficacy of Bariatric Surgery in the Treatment of Women With Obesity and Polycystic Ovary Syndrome"],"prefix":"10.1210","volume":"107","author":[{"given":"Lili","family":"Hu","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shanghai Jiao Tong University School of Medicine Affiliated Sixth People\u2019s Hospital, Shanghai Clinical Center for Metabolic Diseases, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Diabetes Institute , Shanghai , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Shanghai Jiao Tong University School of Medicine Affiliated Sixth People\u2019s Hospital , Shanghai , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shanghai Jiao Tong University School of Medicine Affiliated Sixth People\u2019s Hospital, Shanghai Clinical Center for Metabolic Diseases, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Diabetes Institute , Shanghai , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Ying","sequence":"additional","affiliation":[{"name":"Department of Ultrasound in Medicine, Shanghai Institute of Ultrasound in Medicine, Shanghai Jiao Tong University School of Medicine Affiliated Sixth People\u2019s Hospital , Shanghai 200233 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minzhi","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Ultrasound in Medicine, Shanghai Institute of Ultrasound in Medicine, Shanghai Jiao Tong University School of Medicine Affiliated Sixth People\u2019s Hospital , Shanghai 200233 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhua","family":"Zou","sequence":"additional","affiliation":[{"name":"International Peace Maternity and Child Health Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai 200233 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8621-4960","authenticated-orcid":false,"given":"Haoyong","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shanghai Jiao Tong University School of Medicine Affiliated Sixth People\u2019s Hospital, Shanghai Clinical Center for Metabolic Diseases, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Diabetes Institute , Shanghai , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9826-3583","authenticated-orcid":false,"given":"Jun","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shanghai Jiao Tong University School of Medicine Affiliated Sixth People\u2019s Hospital, Shanghai Clinical Center for Metabolic Diseases, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Diabetes Institute , Shanghai , China"},{"name":"Department of Endocrinology and Metabolism, Shanghai Eighth People\u2019s Hospital , Shanghai , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2022,5,12]]},"reference":[{"issue":"6","key":"2022071417245032500_CIT0001","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/humupd\/dmw025","article-title":"The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance","volume":"22","author":"Balen","year":"2016","journal-title":"Hum Reprod Update."},{"issue":"1","key":"2022071417245032500_CIT0002","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12958-019-0509-4","article-title":"Polycystic ovary syndrome and mitochondrial dysfunction","volume":"17","author":"Zhang","year":"2019","journal-title":"Reprod Biol Endocrinol."},{"issue":"12","key":"2022071417245032500_CIT0003","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.tem.2018.08.005","article-title":"New perspectives on the pathogenesis of PCOS: neuroendocrine origins","volume":"29","author":"Walters","year":"2018","journal-title":"Trends Endocrinol Metab."},{"key":"2022071417245032500_CIT0004","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jsbmb.2018.04.008","article-title":"Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy","volume":"182","author":"Patel","year":"2018","journal-title":"J Steroid Biochem Mol Biol."},{"issue":"6","key":"2022071417245032500_CIT0005","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1097\/AOG.0000000000002656","article-title":"ACOG Practice Bulletin No. 194: polycystic ovary syndrome","volume":"131","author":"American College of Obstetricians and Gynecologists\u2019 Committee on Practice Bulletins\u2014Gynecology","year":"2018","journal-title":"Obstet Gynecol."},{"issue":"5","key":"2022071417245032500_CIT0006","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nat Rev Endocrinol."},{"issue":"6","key":"2022071417245032500_CIT0007","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.fertnstert.2021.03.024","article-title":"Polycystic ovary syndrome: an intrinsic risk factor for diabetes compounded by obesity","volume":"115","author":"Teede","year":"2021","journal-title":"Fertil Steril."},{"issue":"7","key":"2022071417245032500_CIT0008","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.tcm.2019.08.010","article-title":"Polycystic ovary syndrome and cardiometabolic risk: Opportunities for cardiovascular disease prevention","volume":"30","author":"Osibogun","year":"2020","journal-title":"Trends Cardiovasc Med."},{"issue":"3","key":"2022071417245032500_CIT0009","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.fertnstert.2021.04.018","article-title":"Higher risk of type 2 diabetes in women with hyperandrogenic polycystic ovary syndrome","volume":"116","author":"Persson","year":"2021","journal-title":"Fertil Steril."},{"issue":"4","key":"2022071417245032500_CIT0010","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/humupd\/dmy007","article-title":"Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression","volume":"24","author":"Kakoly","year":"2018","journal-title":"Hum Reprod Update."},{"issue":"5","key":"2022071417245032500_CIT0011","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.fertnstert.2018.08.021","article-title":"Beyond fertility: polycystic ovary syndrome and long-term health","volume":"110","author":"Cooney","year":"2018","journal-title":"Fertil Steril."},{"issue":"5","key":"2022071417245032500_CIT0012","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/humupd\/dmv029","article-title":"Pregnancy complications in women with polycystic ovary syndrome","volume":"21","author":"Palomba","year":"2015","journal-title":"Hum Reprod Update"},{"issue":"2","key":"2022071417245032500_CIT0013","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2265.1990.tb00857.x","article-title":"Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases","volume":"32","author":"Kiddy","year":"1990","journal-title":"Clin Endocrinol (Oxf)."},{"key":"2022071417245032500_CIT0014","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1741-7015-8-41","article-title":"Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan","volume":"8","author":"Teede","year":"2010","journal-title":"BMC Med."},{"issue":"1","key":"2022071417245032500_CIT0015","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMcp1514916","article-title":"CLINICAL PRACTICE. polycystic ovary syndrome","volume":"375","author":"McCartney","year":"2016","journal-title":"N Engl J Med."},{"issue":"3","key":"2022071417245032500_CIT0016","doi-asserted-by":"crossref","first-page":"173","DOI":"10.7150\/jca.8009","article-title":"Combination of diane-35 and metformin to treat early endometrial carcinoma in PCOS women with insulin resistance","volume":"5","author":"Li","year":"2014","journal-title":"J Cancer."},{"issue":"12","key":"2022071417245032500_CIT0017","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"issue":"7","key":"2022071417245032500_CIT0018","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1210\/jc.2014-1135","article-title":"Body composition is improved during 12 months\u2019 treatment with metformin alone or combined with oral contraceptives compared with treatment with oral contraceptives in polycystic ovary syndrome","volume":"99","author":"Glintborg","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2022071417245032500_CIT0019","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.contraception.2012.07.005","article-title":"Body composition in lean women with polycystic ovary syndrome: effect of ethinyl estradiol and drospirenone combination","volume":"87","author":"Aydin","year":"2013","journal-title":"Contraception."},{"issue":"3","key":"2022071417245032500_CIT0020","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2265.2012.04415.x","article-title":"Ethinyl estradiol-drospirenone vs ethinyl estradiol-drospirenone plus metformin in the treatment of lean women with polycystic ovary syndrome","volume":"78","author":"Cinar","year":"2013","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"6","key":"2022071417245032500_CIT0021","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jacc.2017.12.014","article-title":"Metabolic surgery: weight loss, diabetes, and beyond","volume":"71","author":"Pareek","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"2022071417245032500_CIT0022","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1007\/s11695-020-04487-3","article-title":"Impact of bariatric surgery on clinical, biochemical, and hormonal parameters in women with polycystic ovary syndrome (PCOS)","volume":"30","author":"Singh","year":"2020","journal-title":"Obes Surg."},{"issue":"8","key":"2022071417245032500_CIT0023","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1007\/s11695-018-3155-6","article-title":"Bariatric surgery improves hyperandrogenism, menstrual irregularities, and metabolic dysfunction among women with polycystic ovary syndrome (PCOS)","volume":"28","author":"Christ","year":"2018","journal-title":"Obes Surg."},{"issue":"9","key":"2022071417245032500_CIT0024","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.1016\/j.sjbs.2021.05.022","article-title":"Impact of bariatric surgery on androgen profile and ovarian volume in obese polycystic ovary syndrome patients with infertility","volume":"28","author":"Ezzat","year":"2021","journal-title":"Saudi J Biol Sci."},{"issue":"12","key":"2022071417245032500_CIT0025","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1210\/jc.2005-1490","article-title":"The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery","volume":"90","author":"Escobar-Morreale","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"key":"2022071417245032500_CIT0026","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.metabol.2018.11.002","article-title":"Characteristics of obesity in polycystic ovary syndrome: etiology, treatment, and genetics","volume":"92","author":"Glueck","year":"2019","journal-title":"Metabolism."},{"issue":"5","key":"2022071417245032500_CIT0027","doi-asserted-by":"crossref","first-page":"299","DOI":"10.5582\/bst.2021.01287","article-title":"Formulation and interpretation of the Chinese guidelines for surgical treatment of obesity and type 2 diabetes mellitus","volume":"15","author":"Du","year":"2021","journal-title":"Biosci Trends"},{"issue":"1","key":"2022071417245032500_CIT0028","first-page":"2","article-title":"Polycystic ovary syndrome: a review","author":"Endocrinology Group and Guideline Expert Group, Chinese Society of Obstetrics and Gynecology in Chinese.","year":"2018","journal-title":"Chin J Gynecol"},{"issue":"7","key":"2022071417245032500_CIT0029","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia."},{"issue":"7","key":"2022071417245032500_CIT0030","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3109\/09513590.2015.1029447","article-title":"Metabolic profile of Diane-35 versus Diane-35 plus metformin in Chinese PCOS women under standardized life-style changes","volume":"31","author":"Wu","year":"2015","journal-title":"Gynecol Endocrinol."},{"key":"2022071417245032500_CIT0031","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1477-7827-12-3","article-title":"Metformin and gonadotropins for ovulation induction in patients with polycystic ovary syndrome: a systematic review with meta-analysis of randomized controlled trials","volume":"12","author":"Palomba","year":"2014","journal-title":"Reprod Biol Endocrinol."},{"issue":"5","key":"2022071417245032500_CIT0032","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr Rev."},{"key":"2022071417245032500_CIT0033","doi-asserted-by":"crossref","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome","volume":"2","author":"Azziz","year":"2016","journal-title":"Nat Rev Dis Primers."},{"issue":"4","key":"2022071417245032500_CIT0034","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.fertnstert.2016.08.031","article-title":"Polycystic ovary syndrome and environmental toxins","volume":"106","author":"Rutkowska","year":"2016","journal-title":"Fertil Steril."},{"issue":"1","key":"2022071417245032500_CIT0035","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1017\/S0954422416000287","article-title":"Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges","volume":"30","author":"Jeanes","year":"2017","journal-title":"Nutr Res Rev."},{"issue":"3","key":"2022071417245032500_CIT0036","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.metabol.2003.10.005","article-title":"Pathogenesis of polycystic ovary syndrome: what is the role of obesity?","volume":"53","author":"Salehi","year":"2004","journal-title":"Metabolism."},{"issue":"10","key":"2022071417245032500_CIT0037","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1007\/s00125-012-2638-6","article-title":"Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"55","author":"Wojciechowski","year":"2012","journal-title":"Diabetologia."},{"issue":"4","key":"2022071417245032500_CIT0038","first-page":"1470","article-title":"Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone","volume":"84","author":"Huber-Buchholz","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2022071417245032500_CIT0039","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1093\/humrep\/13.6.1502","article-title":"Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment","volume":"13","author":"Clark","year":"1998","journal-title":"Hum Reprod."},{"issue":"3","key":"2022071417245032500_CIT0040","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2265.1993.tb02378.x","article-title":"Response of sex hormone binding globulin and insulin-like growth factor binding protein-1 to an oral glucose tolerance test in obese women with polycystic ovary syndrome before and after calorie restriction","volume":"39","author":"Hamilton-Fairley","year":"1993","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"11","key":"2022071417245032500_CIT0041","first-page":"CD003053","article-title":"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility","volume":"11","author":"Morley","year":"2017","journal-title":"Cochrane Database Syst Rev."},{"issue":"9","key":"2022071417245032500_CIT0042","doi-asserted-by":"crossref","first-page":"dgaa439","DOI":"10.1210\/clinem\/dgaa439","article-title":"Fertility and pregnancy outcomes in women with polycystic ovary syndrome following bariatric surgery","volume":"105","author":"Benito","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2022071417245032500_CIT0043","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11695-018-3473-8","article-title":"Sleeve gastrectomy for obesity in polycystic ovarian syndrome: a pilot study evaluating weight loss and fertility outcomes","volume":"29","author":"Dilday","year":"2019","journal-title":"Obes Surg."},{"issue":"6","key":"2022071417245032500_CIT0044","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr Rev."},{"issue":"6","key":"2022071417245032500_CIT0045","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.fertnstert.2008.09.018","article-title":"Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society","volume":"92","author":"Moran","year":"2009","journal-title":"Fertil Steril."},{"issue":"9","key":"2022071417245032500_CIT0046","first-page":"2586","article-title":"Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome","volume":"80","author":"Holte","year":"1995","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022071417245032500_CIT0047","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.rbmo.2021.05.008","article-title":"Improvements in PCOS characteristics and phenotype severity during a randomized controlled lifestyle intervention","volume":"43","author":"Dietz de Loos","year":"2021","journal-title":"Reprod Biomed Online."},{"issue":"1","key":"2022071417245032500_CIT0048","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.rbmo.2017.03.023","article-title":"Effects of liraglutide on ovarian dysfunction in polycystic ovary syndrome: a randomized clinical trial","volume":"35","author":"Nylander","year":"2017","journal-title":"Reprod Biomed Online."},{"issue":"4","key":"2022071417245032500_CIT0049","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.fertnstert.2004.02.127","article-title":"Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity","volume":"82","author":"Baillargeon","year":"2004","journal-title":"Fertil Steril."},{"issue":"5","key":"2022071417245032500_CIT0050","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ajog.2004.05.030","article-title":"Does metformin induce ovulation in normoandrogenic anovulatory women?","volume":"191","author":"Carmina","year":"2004","journal-title":"Am J Obstet Gynecol."},{"issue":"2","key":"2022071417245032500_CIT0051","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ejogrb.2005.05.010","article-title":"Predictive value of glucose-insulin ratio in PCOS and profile of women who will benefit from metformin therapy: obese, lean, hyper or normoinsulinemic?","volume":"123","author":"Onalan","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"issue":"4","key":"2022071417245032500_CIT0052","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1365-2265.2011.04093.x","article-title":"Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome","volume":"75","author":"Gangale","year":"2011","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"11","key":"2022071417245032500_CIT0053","first-page":"959","article-title":"Multidisciplinary clinical consensus on diagnosis and treatment of obesity (2021 edition)","volume":"37","author":"Chinese Society of Endocrinology (CSE)","year":"2021","journal-title":"Chin J Endocrinol Metab."},{"issue":"6","key":"2022071417245032500_CIT0054","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1007\/s00464-020-07555-y","article-title":"Clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO-EC, EASO and ESPCOP","volume":"34","author":"Di Lorenzo","year":"2020","journal-title":"Surg Endosc."},{"issue":"4","key":"2022071417245032500_CIT0055","doi-asserted-by":"crossref","first-page":"O1","DOI":"10.1002\/oby.22719","article-title":"Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures - 2019 update: Cosponsored by American Association of Clinical Endocrinologists\/American College of Endocrinology, The Obesity Society, American Society for Metabolic and Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists","volume":"28","author":"Mechanick","year":"2020","journal-title":"Obesity (Silver Spring)."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgac294\/43906688\/dgac294.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/8\/e3217\/44886623\/dgac294.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/8\/e3217\/44886623\/dgac294.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T17:36:08Z","timestamp":1657820168000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/107\/8\/e3217\/6584786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,12]]},"references-count":55,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,5,12]]},"published-print":{"date-parts":[[2022,7,14]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgac294","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,8,1]]},"published":{"date-parts":[[2022,5,12]]}}}